BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

It seems our licencee, Regen, is making some progress in its...

  1. Hoyland
    4,015 Posts.
    lightbulb Created with Sketch. 127
    clock Created with Sketch.
    02/08/14
    13:01
    Post #: 13759112
    It seems our licencee, Regen, is making some progress in its efforts to get its breast cancer drug into the clinic. Clearly they too are behind their published schedule but they are heading in the right direction.

    BLT Price at posting: 99.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.